BioPorto A/S (CPH:BIOPOR)
Denmark · Delayed Price · Currency is DKK 1.020
+0.006 (0.59%)
Jan 23, 2026, 9:53 AM CET
BioPorto Market Cap
BioPorto has a market cap or net worth of 502.03 million as of January 23, 2026. Its market cap has decreased by -30.53% in one year.
Market Cap
502.03M
Enterprise Value
482.77M
Revenue
36.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.02
Market Cap Chart
Since March 1, 2005, BioPorto's market cap has increased from 75.28M to 502.03M, an increase of 566.89%. That is a compound annual growth rate of 9.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 502.03M | -0.59% |
| Dec 30, 2025 | 505.00M | -24.17% |
| Dec 30, 2024 | 665.97M | -16.07% |
| Dec 29, 2023 | 793.48M | 2.41% |
| Dec 30, 2022 | 774.78M | 17.16% |
| Dec 30, 2021 | 661.32M | -38.59% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.73T |
| Genmab | 123.08B |
| Coloplast | 121.43B |
| ALK-Abelló | 49.28B |
| ChemoMetec | 12.06B |
| Gubra | 7.24B |
| Pharma Equity Group | 131.96M |
| ViroGates | 103.03M |